Discovery of Novel Herpes Simplexviruses in Wild Gorillas, Bonobos, and Chimpanzees Supports Zoonotic Origin of HSV-2.


Journal

Molecular biology and evolution
ISSN: 1537-1719
Titre abrégé: Mol Biol Evol
Pays: United States
ID NLM: 8501455

Informations de publication

Date de publication:
25 06 2021
Historique:
pubmed: 16 3 2021
medline: 22 9 2021
entrez: 15 3 2021
Statut: ppublish

Résumé

Viruses closely related to human pathogens can reveal the origins of human infectious diseases. Human herpes simplexvirus type 1 (HSV-1) and type 2 (HSV-2) are hypothesized to have arisen via host-virus codivergence and cross-species transmission. We report the discovery of novel herpes simplexviruses during a large-scale screening of fecal samples from wild gorillas, bonobos, and chimpanzees. Phylogenetic analysis indicates that, contrary to expectation, simplexviruses from these African apes are all more closely related to HSV-2 than to HSV-1. Molecular clock-based hypothesis testing suggests the divergence between HSV-1 and the African great ape simplexviruses likely represents a codivergence event between humans and gorillas. The simplexviruses infecting African great apes subsequently experienced multiple cross-species transmission events over the past 3 My, the most recent of which occurred between humans and bonobos around 1 Ma. These findings revise our understanding of the origins of human herpes simplexviruses and suggest that HSV-2 is one of the earliest zoonotic pathogens.

Identifiants

pubmed: 33720357
pii: 6171151
doi: 10.1093/molbev/msab072
pmc: PMC8233514
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2818-2830

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI135992
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI115701
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.

Références

Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Philos Trans R Soc Lond B Biol Sci. 2010 Oct 27;365(1556):3277-88
pubmed: 20855302
J Clin Microbiol. 1989 Jun;27(6):1357-66
pubmed: 2546978
J Med Primatol. 2007 Aug;36(4-5):172-9
pubmed: 17669206
Mol Biol Evol. 2019 Jan 1;36(1):174-176
pubmed: 30351416
J Virol. 2016 Jul 27;90(16):7184-95
pubmed: 27252529
J Virol. 2012 Sep;86(18):9558-65
pubmed: 22761371
Nature. 2009 Jun 25;459(7250):1122-5
pubmed: 19516283
Syst Biol. 2016 Mar;65(2):250-64
pubmed: 26526428
Mol Biol Evol. 2015 Aug;32(8):2072-84
pubmed: 25862141
Syst Biol. 2003 Feb;52(1):37-47
pubmed: 12554438
PLoS One. 2017 Oct 26;12(10):e0185056
pubmed: 29073143
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Science. 2019 Mar 29;363(6434):1453-1455
pubmed: 30846610
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Nature. 2010 Sep 23;467(7314):420-5
pubmed: 20864995
Mol Ecol. 2013 Feb;22(4):915-24
pubmed: 23298293
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Arch Virol. 2009;154(1):171-7
pubmed: 19066710
Elife. 2018 Jan 16;7:
pubmed: 29336306
PLoS One. 2012;7(11):e49521
pubmed: 23166696
Mol Biol Evol. 2011 Jan;28(1):523-32
pubmed: 20801907
PLoS Biol. 2006 May;4(5):e88
pubmed: 16683862
Mol Biol Evol. 2016 Jun;33(6):1635-8
pubmed: 26921390
J Virol. 2006 Feb;80(3):1214-21
pubmed: 16414998
Nature. 2005 Dec 1;438(7068):575-6
pubmed: 16319873
J Med Primatol. 1992 Jul;21(5):246-51
pubmed: 1328641
PLoS One. 2011;6(7):e22527
pubmed: 21799886
Syst Biol. 2011 Mar;60(2):150-60
pubmed: 21187451
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15716-21
pubmed: 22891323
Virus Evol. 2015 May 26;1(1):vev003
pubmed: 27774277
Mol Biol Evol. 2014 Sep;31(9):2356-64
pubmed: 24916030
Mol Biol Evol. 2015 May;32(5):1365-71
pubmed: 25701167
PLoS Genet. 2011 Mar;7(3):e1001342
pubmed: 21436896
Curr Biol. 2016 Dec 19;26(24):3407-3412
pubmed: 27939314
Mol Biol Evol. 2011 Dec;28(12):3355-65
pubmed: 21705379
Bioinformatics. 2012 Jun 15;28(12):1647-9
pubmed: 22543367
Arch Virol. 2013 Aug;158(8):1825-8
pubmed: 23508549
Ann Hum Biol. 2017 Aug;44(5):397-407
pubmed: 28511559
J Virol. 2003 Oct;77(20):10731-9
pubmed: 14512523
J Infect Dis. 2002 Oct 15;186 Suppl 1:S3-28
pubmed: 12353183
Mol Biol Evol. 2018 Mar 1;35(3):773-777
pubmed: 29301006
Curr Opin Genet Dev. 2020 Jun;62:58-64
pubmed: 32634682
J Hum Evol. 2005 Mar;48(3):237-57
pubmed: 15737392
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006841
pubmed: 22229120
Syst Biol. 2006 Apr;55(2):195-207
pubmed: 16522570
Science. 2020 Jun 19;368(6497):1367-1370
pubmed: 32554594
Am J Epidemiol. 2018 Dec 1;187(12):2498-2502
pubmed: 30508193
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Clin Microbiol Infect. 2012 Jun;18(6):521-7
pubmed: 22448813
Mol Biol Evol. 2017 Jul 1;34(7):1713-1721
pubmed: 28369565
Lancet Infect Dis. 2014 Apr;14(4):319-26
pubmed: 24480148
Mol Biol Evol. 2011 Jan;28(1):615-23
pubmed: 20802239
Mol Biol Evol. 2020 Aug 1;37(8):2430-2439
pubmed: 32068869
Syst Biol. 2019 Sep 1;68(5):681-697
pubmed: 30668834
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Mol Phylogenet Evol. 2009 Dec;53(3):808-25
pubmed: 19682589
Arch Virol. 1993;129(1-4):167-82
pubmed: 8385913
Nature. 2017 Aug 2;548(7665):82-86
pubmed: 28770842
J Mol Biol. 1995 Mar 31;247(3):443-58
pubmed: 7714900
Malar J. 2014 Oct 20;13:413
pubmed: 25331753
Syst Biol. 2018 Jul 1;67(4):594-615
pubmed: 29342307
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
J Virol. 2008 Feb;82(4):1819-26
pubmed: 18057240
J Gen Virol. 2006 Jan;87(Pt 1):11-19
pubmed: 16361413
Mol Biol Evol. 2012 Sep;29(9):2157-67
pubmed: 22403239
J Virol. 2015 Aug;89(16):8206-18
pubmed: 26018161

Auteurs

Joel O Wertheim (JO)

Department of Medicine, University of California San Diego, San Diego, CA, USA.

Reilly Hostager (R)

Department of Medicine, University of California San Diego, San Diego, CA, USA.

Diane Ryu (D)

Viral Evolution, Robert Koch Institute, Berlin, Germany.
Epidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.

Kevin Merkel (K)

Viral Evolution, Robert Koch Institute, Berlin, Germany.
Epidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.

Samuel Angedakin (S)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Mimi Arandjelovic (M)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Emmanuel Ayuk Ayimisin (EA)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Fred Babweteera (F)

Budongo Conservation Field Station, Masindi, Uganda.

Mattia Bessone (M)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.
School of Biological & Environmental Sciences, Liverpool John Moores University, Liverpool, United Kingdom.

Kathryn J Brun-Jeffery (KJ)

Faculty of Natural Sciences, University of Stirling, Stirling, United Kingdom.

Paula Dieguez (P)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Winnie Eckardt (W)

Dian Fossey Gorilla Fund International, Atlanta, GA, USA.
Department of Environmental Sciences and Program in Population Biology, Ecology and Evolution, Emory University, Druid Hills, GA, USA.

Barbara Fruth (B)

School of Biological & Environmental Sciences, Liverpool John Moores University, Liverpool, United Kingdom.
Centre for Research and Conservation, Royal Zoological Society of Antwerp, Antwerp, Belgium.

Ilka Herbinger (I)

WWF Germany, Berlin, Germany.

Sorrel Jones (S)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.
Royal Society for the Protection of Birds, Centre for Conservation Science, Cambridge, United Kingdom.

Hjalmar Kuehl (H)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.
German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, Leipzig, Germany.

Kevin E Langergraber (KE)

School of Human Evolution and Social Change, Arizona State University, Tempe, AZ, USA.
Institute of Human Origins, Arizona State University, Tempe, AZ, USA.

Kevin Lee (K)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.
School of Human Evolution and Social Change, Arizona State University, Tempe, AZ, USA.
Institute of Human Origins, Arizona State University, Tempe, AZ, USA.

Nadege F Madinda (NF)

Epidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.
Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Sonja Metzger (S)

Epidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.
Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Lucy Jayne Ormsby (LJ)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Martha M Robbins (MM)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Volker Sommer (V)

Department of Anthropology, University College London, London, United Kingdom.
Gashaka Primate Project, Serti/Taraba, Nigeria.

Tara Stoinski (T)

Dian Fossey Gorilla Fund International, Atlanta, GA, USA.
Department of Environmental Sciences and Program in Population Biology, Ecology and Evolution, Emory University, Druid Hills, GA, USA.

Erin G Wessling (EG)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.
Human Evolutionary Biology, Harvard University, Cambridge, MA, USA.

Roman M Wittig (RM)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Yisa Ginath Yuh (YG)

Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.

Fabian H Leendertz (FH)

Epidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.

Sébastien Calvignac-Spencer (S)

Viral Evolution, Robert Koch Institute, Berlin, Germany.
Epidemiology of Highly Pathogenic Microorganisms, Robert Koch Institute, Berlin, Germany.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH